Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03300284 · ClinicalTrials.gov registry record

Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer

A clinical trial of Thyroid Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
186
Enrollment target
5
Study locations

NCT03300284: Completed study of Thyroid Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03300284 is a study of Thyroid Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 186 participants, below the 278-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (33% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03300284, a study of Thyroid Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
186 participants
Enrollment target
5
Study locations

Study Summary

This study is being done to understand the decision-making process regarding management choice in low-risk papillary thyroid cancer.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaires

Study Locations (5)

New York

  • MAIMONIDES MEDICAL CENTER (Data collection only) - Brooklyn
  • Memorial Sloan Kettering Cancer Center - New York

Connecticut

  • Hartford Healthcare (Data Collection) - Hartford

New Jersey

  • Memorial Sloan Kettering Monmouth (Consent and Follow up) - Middletown

Pennsylvania

  • Lehigh Valley Health Network - Allentown

Trial Details

FieldValue
Enrollment Target 186 participants
Start Date 2017-08-07
Est. Completion 2023-07-13

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03300284

The ClinicalTrials.gov registry entry for NCT03300284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 278-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (33% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thyroid Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.

NCT03300284 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, Connecticut, New Jersey.

Frequently Asked Questions

What is clinical trial NCT03300284 about?

NCT03300284 is a clinical study titled "Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer". This study is being done to understand the decision-making process regarding management choice in low-risk papillary thyroid cancer.

What is the current status of trial NCT03300284?

This trial is currently completed. The enrollment target is 186 participants. The study started on 2017-08-07. Estimated completion is 2023-07-13.

What conditions does trial NCT03300284 study?

This clinical trial studies the following conditions: Thyroid Cancer.

What interventions are being tested in trial NCT03300284?

The interventions under investigation include: Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT03300284?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03300284 being conducted?

This trial has 5 study locations across Connecticut, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.